nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—Betamethasone—Triamcinolone—alopecia areata	0.0686	0.5	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—alopecia areata	0.0686	0.5	CbGdCrCtD
Irbesartan—AGTR1—Allograft Rejection—CXCL9—alopecia areata	0.038	0.0484	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PRDX5—alopecia areata	0.0336	0.0429	CbGpPWpGaD
Irbesartan—EDNRA—Peptide GPCRs—CXCR3—alopecia areata	0.0328	0.0419	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Other—CXCR3—alopecia areata	0.0278	0.0355	CbGpPWpGaD
Irbesartan—AGTR1—Peptide GPCRs—CXCR3—alopecia areata	0.0258	0.0329	CbGpPWpGaD
Irbesartan—JUN—Calcium signaling in the CD4+ TCR pathway—IL2RA—alopecia areata	0.0252	0.0321	CbGpPWpGaD
Irbesartan—JUN—IL12 signaling mediated by STAT4—IL2RA—alopecia areata	0.0245	0.0313	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.024	0.0306	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—alopecia areata	0.0235	0.03	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL9—alopecia areata	0.0231	0.0295	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—CTLA4—alopecia areata	0.0218	0.0278	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—PRDX5—alopecia areata	0.02	0.0255	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.0188	0.024	CbGpPWpGaD
Irbesartan—JUN—IL-2 Signaling Pathway—IL2RA—alopecia areata	0.0187	0.0239	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL9—alopecia areata	0.018	0.023	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—alopecia areata	0.0163	0.0208	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.0161	0.0205	CbGpPWpGaD
Irbesartan—JUN—IL12 signaling mediated by STAT4—CD4—alopecia areata	0.0156	0.0199	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.0154	0.0197	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—IL2RA—alopecia areata	0.0153	0.0195	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL2RA—alopecia areata	0.0151	0.0193	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—CD8A—alopecia areata	0.0145	0.0185	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—IL2RA—alopecia areata	0.013	0.0166	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.0126	0.0161	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.0125	0.0159	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL9—alopecia areata	0.0122	0.0156	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.0121	0.0155	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.0121	0.0154	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL10—alopecia areata	0.012	0.0154	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—CD8A—alopecia areata	0.0113	0.0144	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.0104	0.0132	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.0098	0.0125	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL9—alopecia areata	0.00961	0.0123	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.00949	0.0121	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL10—alopecia areata	0.0094	0.012	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.00838	0.0107	CbGpPWpGaD
Irbesartan—JUN—Immune System—ULBP3—alopecia areata	0.00823	0.0105	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.00813	0.0104	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCR3—alopecia areata	0.00789	0.0101	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL9—alopecia areata	0.00692	0.00883	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.00657	0.00838	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—CD4—alopecia areata	0.00648	0.00827	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL10—alopecia areata	0.00638	0.00814	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL9—alopecia areata	0.00628	0.00802	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCR3—alopecia areata	0.00619	0.0079	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL9—alopecia areata	0.00543	0.00693	CbGpPWpGaD
Irbesartan—Ear infection—Triamcinolone—alopecia areata	0.00521	0.0661	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—CXCL10—alopecia areata	0.00501	0.00639	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL9—alopecia areata	0.00493	0.00629	CbGpPWpGaD
Irbesartan—Trauma—Triamcinolone—alopecia areata	0.00465	0.059	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—CXCR3—alopecia areata	0.00446	0.00569	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCR3—alopecia areata	0.00405	0.00517	CbGpPWpGaD
Irbesartan—Blindness—Triamcinolone—alopecia areata	0.004	0.0508	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CXCL9—alopecia areata	0.00371	0.00474	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL10—alopecia areata	0.0036	0.0046	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCR3—alopecia areata	0.0035	0.00446	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL10—alopecia areata	0.00327	0.00418	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCR3—alopecia areata	0.00318	0.00405	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL9—alopecia areata	0.00291	0.00372	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL10—alopecia areata	0.00283	0.00361	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2RA—alopecia areata	0.00276	0.00351	CbGpPWpGaD
Irbesartan—Glycosuria—Triamcinolone—alopecia areata	0.00273	0.0347	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—alopecia areata	0.00257	0.00328	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2RA—alopecia areata	0.0025	0.00319	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCR3—alopecia areata	0.00239	0.00305	CbGpPWpGaD
Irbesartan—Vasculitis—Triamcinolone—alopecia areata	0.00227	0.0288	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CXCL9—alopecia areata	0.00218	0.00278	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2RA—alopecia areata	0.00216	0.00276	CbGpPWpGaD
Irbesartan—Wheezing—Triamcinolone—alopecia areata	0.00215	0.0273	CcSEcCtD
Irbesartan—Ecchymosis—Triamcinolone—alopecia areata	0.002	0.0254	CcSEcCtD
Irbesartan—Pulmonary oedema—Triamcinolone—alopecia areata	0.00197	0.025	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—IL2RA—alopecia areata	0.00196	0.0025	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—alopecia areata	0.00193	0.00247	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—alopecia areata	0.00193	0.00247	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCR3—alopecia areata	0.00188	0.00239	CbGpPWpGaD
Irbesartan—Diabetes mellitus—Triamcinolone—alopecia areata	0.00185	0.0235	CcSEcCtD
Irbesartan—Injury—Triamcinolone—alopecia areata	0.00175	0.0222	CcSEcCtD
Irbesartan—Increased appetite—Triamcinolone—alopecia areata	0.00171	0.0217	CcSEcCtD
Irbesartan—Affect lability—Triamcinolone—alopecia areata	0.00158	0.0201	CcSEcCtD
Irbesartan—Mood swings—Triamcinolone—alopecia areata	0.00152	0.0193	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—alopecia areata	0.00152	0.00194	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—alopecia areata	0.00149	0.0019	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2RA—alopecia areata	0.00148	0.00189	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—alopecia areata	0.00147	0.00187	CbGpPWpGaD
Irbesartan—Muscular weakness—Triamcinolone—alopecia areata	0.00142	0.018	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CXCR3—alopecia areata	0.0014	0.00179	CbGpPWpGaD
Irbesartan—Abdominal distension—Triamcinolone—alopecia areata	0.0014	0.0177	CcSEcCtD
Irbesartan—Influenza—Triamcinolone—alopecia areata	0.00139	0.0176	CcSEcCtD
Irbesartan—Asthma—Triamcinolone—alopecia areata	0.00139	0.0176	CcSEcCtD
Irbesartan—Pancreatitis—Triamcinolone—alopecia areata	0.00136	0.0173	CcSEcCtD
Irbesartan—JUN—Immune System—IL2RA—alopecia areata	0.00134	0.00171	CbGpPWpGaD
Irbesartan—Upper respiratory tract infection—Triamcinolone—alopecia areata	0.00129	0.0164	CcSEcCtD
Irbesartan—Weight increased—Triamcinolone—alopecia areata	0.00126	0.016	CcSEcCtD
Irbesartan—Acute coronary syndrome—Triamcinolone—alopecia areata	0.00122	0.0155	CcSEcCtD
Irbesartan—Myocardial infarction—Triamcinolone—alopecia areata	0.00121	0.0154	CcSEcCtD
Irbesartan—Conjunctivitis—Triamcinolone—alopecia areata	0.0012	0.0153	CcSEcCtD
Irbesartan—Epistaxis—Triamcinolone—alopecia areata	0.00117	0.0148	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—alopecia areata	0.00116	0.00148	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—alopecia areata	0.00113	0.00145	CbGpPWpGaD
Irbesartan—Bradycardia—Triamcinolone—alopecia areata	0.00113	0.0144	CcSEcCtD
Irbesartan—Rhinitis—Triamcinolone—alopecia areata	0.00112	0.0141	CcSEcCtD
Irbesartan—Pharyngitis—Triamcinolone—alopecia areata	0.0011	0.014	CcSEcCtD
Irbesartan—Arrhythmia—Triamcinolone—alopecia areata	0.000994	0.0126	CcSEcCtD
Irbesartan—Erythema—Triamcinolone—alopecia areata	0.000968	0.0123	CcSEcCtD
Irbesartan—Dysgeusia—Triamcinolone—alopecia areata	0.000948	0.012	CcSEcCtD
Irbesartan—Ill-defined disorder—Triamcinolone—alopecia areata	0.000898	0.0114	CcSEcCtD
Irbesartan—Angioedema—Triamcinolone—alopecia areata	0.000885	0.0112	CcSEcCtD
Irbesartan—Malaise—Triamcinolone—alopecia areata	0.000873	0.0111	CcSEcCtD
Irbesartan—Vertigo—Triamcinolone—alopecia areata	0.00087	0.011	CcSEcCtD
Irbesartan—Syncope—Triamcinolone—alopecia areata	0.000868	0.011	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—IL2RA—alopecia areata	0.000866	0.00111	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—alopecia areata	0.000854	0.00109	CbGpPWpGaD
Irbesartan—Loss of consciousness—Triamcinolone—alopecia areata	0.000851	0.0108	CcSEcCtD
Irbesartan—Cough—Triamcinolone—alopecia areata	0.000845	0.0107	CcSEcCtD
Irbesartan—Hypertension—Triamcinolone—alopecia areata	0.000836	0.0106	CcSEcCtD
Irbesartan—Myalgia—Triamcinolone—alopecia areata	0.000824	0.0105	CcSEcCtD
Irbesartan—Discomfort—Triamcinolone—alopecia areata	0.000814	0.0103	CcSEcCtD
Irbesartan—Dry mouth—Triamcinolone—alopecia areata	0.000806	0.0102	CcSEcCtD
Irbesartan—Anaphylactic shock—Triamcinolone—alopecia areata	0.00079	0.01	CcSEcCtD
Irbesartan—Oedema—Triamcinolone—alopecia areata	0.00079	0.01	CcSEcCtD
Irbesartan—Infection—Triamcinolone—alopecia areata	0.000785	0.00996	CcSEcCtD
Irbesartan—Shock—Triamcinolone—alopecia areata	0.000778	0.00986	CcSEcCtD
Irbesartan—Tachycardia—Triamcinolone—alopecia areata	0.000771	0.00978	CcSEcCtD
Irbesartan—Hyperhidrosis—Triamcinolone—alopecia areata	0.000764	0.00969	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—alopecia areata	0.00072	0.00913	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—alopecia areata	0.00071	0.009	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—alopecia areata	0.000705	0.00894	CcSEcCtD
Irbesartan—Dyspepsia—Triamcinolone—alopecia areata	0.000696	0.00883	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—alopecia areata	0.000681	0.00864	CcSEcCtD
Irbesartan—Pain—Triamcinolone—alopecia areata	0.000676	0.00857	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—alopecia areata	0.000651	0.00826	CcSEcCtD
Irbesartan—Urticaria—Triamcinolone—alopecia areata	0.000628	0.00796	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—alopecia areata	0.000625	0.00793	CcSEcCtD
Irbesartan—Hypersensitivity—Triamcinolone—alopecia areata	0.000582	0.00739	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—alopecia areata	0.000567	0.00719	CcSEcCtD
Irbesartan—Pruritus—Triamcinolone—alopecia areata	0.000559	0.00709	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—alopecia areata	0.000523	0.00663	CcSEcCtD
Irbesartan—Vomiting—Triamcinolone—alopecia areata	0.000502	0.00637	CcSEcCtD
Irbesartan—Rash—Triamcinolone—alopecia areata	0.000498	0.00632	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—alopecia areata	0.000498	0.00632	CcSEcCtD
Irbesartan—Headache—Triamcinolone—alopecia areata	0.000495	0.00628	CcSEcCtD
Irbesartan—Nausea—Triamcinolone—alopecia areata	0.000469	0.00596	CcSEcCtD
